Sign in →

Test Code CMVQN Cytomegalovirus PCR Quantitative

EHR Test Codes

  Test Code Test Name
Atlas CMVQN CMV DNA Dectection and Quant, PCR
Cerner   Cytomegalovirus PCR Quantitative

Specimen Requirements

Preparation of Patient: 

None

 

Container Type: 

6mL EDTA Lavender Top Tube

Specimen Type:

Plasma

 

Specimen Volume: 

3.0 mL Plasma  minimum 1.5 mL

 

Specimen Handling/Transport:

Transport ambient room temperature and or refrigerated 2 -8°C

 

Specimen Stability/Storage:

Whole Blood 24 hours ambient room temperature

Plasma 6 day 2 - 8°C

Plasma >6 day -20°C

Performing Laboratory

Munson Medical Center Laboratories

Microbiology Department

Priority, Frequency, & Turnaround

Priority:

Non-Emergent

 

Frequency:

Monday and Thursday

 

Turnaround:

0 - 5 days

Methodology

RT-PCR

Reporting

Reference Range:

Not Detected

 

Interpretive Data:

The quantification range of this assay is 34.5 to 10,000,000 IU/mL (1.54 log to 7.00 log IU/mL). Test performed on the Roche Cobas 6800 by RT-PCR, a Nucleic Acid Amplification method.
 

Critical Decision: 

None

Clinical Significance

CMV PCR identifies the presence of CMV DNA supporting diagnosis of an active or current CMV infection. 

 

Human cytomegalovirus (CMV) is a viral pathogen belonging to the herpes virus family found ubiquitously in communities worldwide. In immunocompetent hosts, infections with CMV are often asymptomatic but primary lytic infection can present as an acute mononucleosis-like syndrome. Once acquired, CMV usually persists as a lifelong latent infection that may reactivate intermittently. Peripheral blood mononuclear cells of the myeloid lineage (but not lymphocytes) and endothelial cells appear to be the major sites of CMV infection. CMV remains in a latent stage in monocytes/macrophages in humans. Latently infected individuals may asymptomatically shed the virus in their body fluids (e.g., urine, saliva) and thus infect others. Immunocompromised individuals, including neonates, transplant recipients, and AIDS patients, are at high risk for developing severe primary CMV infections or reactivations of latent CMV that lead to a high rate of morbidity and mortality. Severe manifestations of CMV disease include retinitis, polyradiculopathy, gastroenteritis, hepatitis, encephalitis, esophagitis, enterocolitis, pancreatitis, nephritis, donor organ rejection, pneumonitis, and CMV viral syndrome.

CPT Code(s)

87497